Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Role of Glucagon in Glucose Metabolism Post-Bariatric Surgery
NCT07212868Phase 1Recruiting
- Sponsor
- UT Health San Antonio
- Start
- Feb 2026
- Primary completion
- May 2030
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised trial of volagidemab (2 arms), sponsored by UT Health San Antonio. Primary endpoints: Glycemic response to meal ingestion and Endogenous glucose production during clamp studies. Started Feb 2026; status: recruiting.
02
Drugs
volagidemab
Beyond the preview
Go deeper on NCT07212868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212868.